Skip to Main Content


2023 Lunch and Learn Series

Registration is now open for the Consortium’s 2023 provider Lunch and Learn series. Click on the hyperlinked topics below to learn more and register for a session on the Colorado Medical Society’s registration page. Each talk has been approved for up to 1 AMA PRA Category 1 credits. Additional details regarding credit can be found […]

2022 fentanyl bill details

HB22-1326: Fentanyl Accountability and Prevention Act Section 1: Legislative declaration Section 2-6: Addresses the proposed criminal penalties for unlawful possession of synthetic opiates and for unlawful manufacturing, distributing, and dispensing of synthetic opiates. Specifically, making it a level 4 drug felony to posses: “Any material, compound, mixture, or preparation that weighs more than one gram […]

Looking into the details of the new fentanyl laws

In the final hours of the 2022 legislative session, the Colorado General Assembly passed HB22-1326, the Fentanyl Accountability and Prevention, which was signed by Governor Polis. The bill received considerable news coverage about the change in law making it a Level 4 drug felony to possess 1-4 grams of fentanyl or any drug of that […]

Benzodiazepine-focused webinar series, sponsored by the Consortium’s Benzodiazepine Action Work Group scheduled for May.

Please join the Colorado Consortium’s Benzodiazepine Action Work Group for our free CME lunch and learn webinar series. Webinar topics include alternative treatments to BZDs, consequences of BZD prescribed use, BZD Induced Neurologic Dysfunction (BIND), and tapering/deprescribing. Prescribers who attend all 4 webinars will be eligible to be listed as a “Benzodiazepine Cooperative Prescriber” in […]

Legislature introduces major bill to prevent fentanyl overdoses, increase criminal penalties

A major bill intended to decrease the number of fentanyl overdose deaths and increase criminal penalties related to fentanyl has been introduced in the General Assembly. The Fentanyl Accountability and Prevention Bill (HB 22-1326) has provisions to make naloxone more available, improve substance use and overdose prevention and education, expand harm reduction services, and to […]

Behavioral Health Transformational Task Force Begins Meetings

The Behavioral Health Transformational Task Force, created by SB21-137, met for the first time on Aug. 17. The group is tasked with issuing a report with recommendations to the General Assembly and the Governor about policies to create transformational change in the area of behavioral health using money the state receives from the federal American […]

2021 Legislative Wrap-Up

The 2021 session of the Colorado General Assembly ended June 8, following a packed calendar that saw the session draw to a close later than usual because of COVID-19 precautions.  This year was a successful one for funding the continuum of services addressing substance use, particularly compared to last year, when budgetary cuts reduced fiscal […]

Telligen honors Consortium as statewide champion

This Colorado Consortium for Prescription Drug Abuse Prevention’s response to joining Telligen to address high priority health issues during COVID-19 and beyond has demonstrated a high level of commitment toward the overall health of Colorado. The pandemic has not only highlighted the importance of community members working together, but also how collaboration can drive community-centered […]